Donald Poon - Concepedia

Author

Donald Poon

National Cancer Centre Singapore

Also Known As

D Y H Poon, D. Poon, Donald Poon, Donald Y. H. Poon, Donald Y.H. Poon, Donald YH Poon, Poon, Donald

Publications

885

Citations

H-Index

Concepts

All Affiliations

National Cancer Centre Singapore Singapore General Hospital Singapore Clinical Research Institute

About

Donald Poon is an author at National Cancer Centre Singapore specializing in medicine, oncology, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	421
2	Health Sciences	4	4	254
3	Cell Biology	1	1	135
4	Geriatrics	1	1	31
5	Hepatology	1	1	37

Donald Poon

Publications

865

Citations

H-Index

Page 1

	Year	Citations
RAD001 (everolimus) inhibits tumour growth in xenograft models of human hepatocellular carcinoma Hung Huynh, Pierce K. H. Chow, Khee Chee Soo, Journal of Cellular and Molecular Medicine Tumour GrowthHuman Hepatocellular CarcinomaXenograft ModelsPathologyMtor Pathway	2008	135
Sorafenib and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma Hung Huynh, Van Chanh Ngo, Heng Nung Koong, Journal of Cellular and Molecular Medicine	2009	129
AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC) Hung Huynh, Van Chanh Ngo, Heng Nung Koong, Journal of Hepatology OncologyHuman Hepatocellular CarcinomaMedicineCancer Cell BiologyPathology	2009	98
Pharmacogenetic profiling across the irinotecan pathway in Asian patients with cancer Qingyu Zhou, Alex Sparreboom, Eng‐Huat Tan, British Journal of Clinical Pharmacology	2005	94
Multicenter Phase II Study of Sequential Radioembolization-Sorafenib Therapy for Inoperable Hepatocellular Carcinoma Pierce K. H. Chow, Donald Poon, Khin Maung Win, PLoS ONE	2014	67
Triplet combination of gemcitabine, paclitaxel, and carboplatin followed by maintenance 5‐fluorouracil and folinic acid in patients with metastatic nasopharyngeal carcinoma Swan Swan Leong, Joseph Wee, Sandeep K. Rajan, Cancer	2008	66
A Randomized Phase II Trial of Single-Agent Gemcitabine, Vinorelbine, or Docetaxel in Patients with Advanced Non-small Cell Lung Cancer Who Have Poor Performance Status and/or Are Elderly Swan Swan Leong, Chee‐Keong Toh, Wan‐Teck Lim, Journal of Thoracic Oncology MedicineSingle-agent GemcitabinePharmacologyClinical TrialsMetronomic Therapy	2007	54
Phase II study of irinotecan (CPT‐11) as salvage therapy for advanced nasopharyngeal carcinoma Donald Poon, Balram Chowbay, Yin‐Bun Cheung, Cancer	2004	53
Concurrent chemoradiotherapy in locoregionally recurrent nasopharyngeal carcinoma Donald Poon, Swee‐Peng Yap, Zee-Wan Wong, International Journal of Radiation OncologyBiologyPhysics Concurrent ChemoradiotherapyRadiation TherapyMedicineNasopharyngeal CancerOncology	2004	51
Dynamic contrast-enhanced CT imaging of hepatocellular carcinoma in cirrhosis: feasibility of a prolonged dual-phase imaging protocol with tracer kinetics modeling Tong San Koh, Choon Hua Thng, Septian Hartono, European Radiology Tracer KineticsHepatologyMedical ImagingHepatocellular CarcinomaBiomedical Imaging	2009	37

Page 1